ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000235927.2	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.024674139	Resistant
ENSG00000235927.2	ABT-263 (navitoclax)	Brain lower grade glioma	0.015355715	Resistant